READ THE PAPER: [ Ссылка ]
Macrini et al. report that MOG-antibodies require the intracellular part of MOG and bivalent binding for MOG-recognition, explaining why a cell-based assay is needed to detect them. As bivalently bound antibodies bind only poorly to C1q, complement activation is probably not the major pathomechanism of MOG-antibodies.
